Twitter Google Share on Facebook factor (redirected fromFactor XIII deficiency) Dictionary Thesaurus Medical Financial Encyclopedia Wikipedia Related to Factor XIII deficiency:Factor xii deficiency An event, circumstance, influence, or element that plays a part in bringing about a result. ...
The risk of recurrent thromboembolism in patients with an Arg506-Gln mutation in the gene for Factor V (Factor V Leiden). N Engl J Med 1997; 336: 399–403. Article CAS Google Scholar Rintelen C, Pabinger I, Knobl P, Lechner K, Mannhalter C . Probability of recurrence of thrombosis...
GENETEST REVIEW Genetics in Medicine Factor V Leiden thrombophilia Jody Lynn Kujovich, MD TABLE OF CONTENTS Pathogenic mechanisms and molecular basis ...2 Prevalence...2 Diagnosis...
Probability of recurrence of thrombosis in patients with and without factor V Leiden. Activated protein C (APC) resistance is a common risk factor for venous thromboembolism and is associated with the replacement of Arg 506 by Gin in the fac... C Rintelen,I Pabinger,P Knöbl,... - 《...
Factor V Leiden mutation and pregnancy - related complications. Am J Obstet Gynecol. 2010, 203, 1-8.Kjellberg U, van Rooijen M, Bremme K, et al. Factor V Leiden mutation and pregnancy-related complications. Am J Obstet Gynecol. 2010;203:469.e1-469.e8....
The presence of factor V Leiden,15 activated protein C (APC) resistance,16 and the prothrombin G20210A gene mutation17 have been associated with stroke in children and young adults. In addition, low levels of protein Z have all been associated with increased risk of stroke.18 APC resistance,...
Evaluation of a Chromogenic Factor VIII-based Assay for the Detection of Factor V Leiden - Evaluation eines chromogenen Faktor VIII-basierten Assays für die Erkennung des Faktor V Leiden The inherited resistance to activated protein C (APC resistance) is a frequent risk factor for thrombosis and...
Age-, sex-, and multivariable-adjusted linear regression was used to estimate the association of the following variants with log-transformed CCA and ICA IMT: factor V Leiden, factor VII Arg/Gln, fibrinogen HindIII beta-148, plasminogen activator inhibitor-1 4G/5G, and the glycoprotein IIIa Pl...
Random screening of the general population for factor V Leiden is not recommended." ● "Patients testing positive for factor V Leiden or APC resistance should be considered for molecular genetic test- ing for […] the prothrombin 20210A variant…" CAP consensus recommendations include the following...
Clinical specificity for the factor V Leiden test has not been firmly established, but can be no lower than 95% (this assumes that all 5% of the population with a mutation are clinical false positives). Similarly, the clinical specificity for the prothrom- bin test is likely to be no ...